Harnovi kills hepatitis C only in 8 weeks

Gilead Sciences’ hepatitis C treatment Harvoni(generic name: ledipasvir/sofosbuvir) have shown excellent efficacy only with a 8-week therapy, not 12 weeks.

Gilead Sciences Korea held a press conference to celebrate expanded health insurance benefits for Harvoni at The Westin Chosun Seoul on the 29^th, and announced real-world clinical data which showed full recovery only with its 8-week, single...